$BBIO (BRIDGEBIO PHARMA) — 8-K: BridgeBio signs U.S. government deal to expand Medicaid access to Attruby

BridgeBio entered a voluntary agreement with the U.S. government to expand state Medicaid access to Attruby via the GENEROUS Model and does not expect to be subject to future pricing mandates. The company said it will continue to offer Attruby via Medicare Part D. ForgingBridges copay assistance remains unchanged, potentially reducing out-of-pocket costs to as little as $0 per month for qualifying patients. Specific terms of the agreement remain confidential.

BridgeBio entered a voluntary agreement with the U.S. government to expand state Medicaid access to Attruby via the GENEROUS Model and does not expect to be subject to future pricing mandates. The company said it will continue to offer Attruby via Medicare Part D. ForgingBridges copay assistance remains unchanged, potentially reducing out-of-pocket costs to as little as $0 per month for qualifying patients. Specific terms of the agreement remain confidential.